Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells

Anti-Cancer Drugs

Volumn 19, Issue 8, 2008, Pages 766-776

  Yeruva, Laxmi ^a,b   Elegbede, John Abiodun ^a   Carper, Stephen W ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Breast cancer; Caspase 8; Membrane fluidity; Mitogen activated protein kinase; Plant compounds

Indexed keywords

CASPASE 3; CASPASE 8; JASMONE; JASMONIC ACID METHYL ESTER; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR RECEPTOR 1; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPENTANE DERIVATIVE; OXYLIPIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BREAST TUMOR; CELL CYCLE; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; DNA FRAGMENTATION; DRUG EFFECT; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ACETIC ACIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 8; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLOPENTANES; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MEMBRANE FLUIDITY; MEMBRANE POTENTIALS; MITOGEN-ACTIVATED PROTEIN KINASES; OXYLIPINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TUMOR STEM CELL ASSAY;

EID: 53749090929     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32830b5894     Document Type: Article

References (38)

1. American Cancer Society, Cancer facts and figures. American Cancer Society Inc., Atlanta, Georgia: 2007.
2. Haag JD, Gould MN. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 1994; 34:477-483.
3. Yuri T, Danbara N, Tsujita-Kyutoku M, Kiyozuka Y, Senzaki H, Shikata N, et al. Perillyl alcohol inhibits human breast cancer cell growth. Breast Cancer Res Treatment 2004; 84:251-260.
4. Bardon S, Foussard V, Fournel S, Loubat A. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett 2002; 181:187-194.
5. Kallio A, Zheng A, Dahllund J, Heiskanen KM, Harkonen P. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells. Apoptosis 2005; 10:1395-1410.
6. Yang HL, Chen CS, Chang WH, Lu FJ, Lai YC, Chen CC, et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorate. Cancer Lett 2006; 231:215-227.
7. Wu CC, Chan ML, Chen WY, Tsai CY, Chang FR, Wu YC. Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria. Mol Cancer Ther 2005; 4:1277-1285.
8. Farmer EE, Ryan CA. Interplant communication: air-borne methyl jasmonate induces synthesis of proteinases inhibitors in plant leaves. Proc Natl Acad Sci U S A 1990; 87:7713-7716.
9. Conti M. Cyclopentenone: a special moiety for anticancer drug design. Anticancer Drugs 2006; 17:1017-1022.
10. Flescher E. Jasmonates-a new family of anti-cancer agents. Anticancer Drugs 2005; 16:911-916.
11. Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res 2005; 65:1984-1993.
12. Kim JH, Lee SY, Oh SY, Han SI, Park HG, Yoo MA, et al. Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells. Oncol Rep 2004; 12:1233-1238.
13. Pinton P, Ferrari D, Di Virgilio F, Pozzan T, Rizzuto R. Molecular machinery and signaling events in apoptosis. Drug Dev Res 2001; 52:558-570.
14. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281:1305-1308.
15. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11:372-377.
16. Mathiasen IS, Hansen CM, Foghsgaard L, Jaatiela M. Sensitization to TNF-induced apoptosis by 1, 25-dihydroxy vitamin D3 involves up-regulation of the TNF receptor 1 cathepsin. B Int J Cancer 2001; 93:224-231.
17. Jin Z, EI-diery WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4:139-163.
18. Lowe LC, Senaratne SG, Colston KW. Induction of apoptosis in breast cancer cells by apomine is mediated by caspase and p38 mitogen activated protein kinase activation. Biochem Biophys Res Commun 2005; 329:772-779.
19. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature 2001; 410:37-40.
20. Caffrey DR, O'Neill LA, Shields DC. The evolution of the MAP kinase pathways: coduplication of interacting proteins leads to new signaling cascades. J Mol Evol 1999; 49:567-582.
21. Takenaka K, Moriguchi T, Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998; 280:599-602.
22. 2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001; 411:102-107.
23. Konishi Y, Lehtinen M, Donovan N, Bonni A. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell 2002; 9:1005-1016.
24. Seger R, Krebs EG. The MAPK signaling cascade. FASEB 1995; 9:726-735.
25. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298:1911- 1912.
26. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, et al. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 1995; 14:951-962.
27. Persons DL, Yazlovitskaya EM, Pelling JC. Effect of extracellular signalregulated kinase on p53 accumulation in response to cisplatin. J Biol Chem 2000; 275:35778-35785.
28. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, et al. Bid-induced conformational change of bax is responsible for mitochondrial cytochrome c release during apoptosis. Cell Biol 1999; 144:891-901.
29. Degli Esposti M, Dive C. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun 2003; 304:455-461.
30. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17:3878-3885.
31. Cain K, Bratton SB, Cohen GM. The Apaf-1 apoptosome: a large caspaseactivating complex. Biochimie 2002; 84:203-214.
32. Yui S, Saeki T, Kanamoto R, Iwami K. Charesteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid. J Biochem 2005; 28:151-157.
33. Smolnikar K, Loffek S, Schulz T, Michna H, Diel P. Treatment with the pure antiestrogen faslodex (ICI182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells. Breast Cancer Res Treat 2000; 63:249-259.
34. Jean-Louis S, Akare S, Ali MA, Mash EA Jr, Meuillet E, Martinez JD. Deoxycholic acid induces intracellular signaling through membrane perturbations. J Biol Chem 2006; 281:14948-14960.
35. Qiao D, Stratagouleas ED, Martinez JD. Activation and role of mitogenactivated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis 2001; 22:35-41.
36. Schlottmann K, Wachs FP, Krieg RC, Kullmann F, Scholmerich J, Rogler G. Characterization of bile salt-induced apoptosis in colon cancer cell lines. Cancer Res 2000; 60:4270-4276.
37. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, et al. A mitochondria-K + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer cell 2007; 11:37-51.
38. Jänicke RU, Engels IH, Dunkern T, Kaina B, Schulze-Osthoff K, Porter AG. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene 2001; 20:5043-5053.